Page last updated: 2024-10-22

ambroxol and Reperfusion Injury

ambroxol has been researched along with Reperfusion Injury in 2 studies

Ambroxol: A metabolite of BROMHEXINE that stimulates mucociliary action and clears the air passages in the respiratory tract. It is usually administered as the hydrochloride.

Reperfusion Injury: Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the tissue (REPERFUSION) following ISCHEMIA.

Research Excerpts

ExcerptRelevanceReference
"The aim of the study is to examine the effect of Ambroxol on TNF-α and IL-1β released after liver ischemia-reperfusion injury."8.12Could Ambroxol reduce cytokines in hepatic ischemia-reperfusion injury in rats? ( Cetinel, S; Gultekin, C; Sayiner, S; Sehirli, AO, 2022)
"The aim of the study is to examine the effect of Ambroxol on TNF-α and IL-1β released after liver ischemia-reperfusion injury."4.12Could Ambroxol reduce cytokines in hepatic ischemia-reperfusion injury in rats? ( Cetinel, S; Gultekin, C; Sayiner, S; Sehirli, AO, 2022)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Gultekin, C1
Sehirli, AO1
Cetinel, S1
Sayiner, S1
Hausen, B1
Bahra, M1
Mueller, P1
Poets, CF1
Hewitt, CW1
Morris, RE1

Other Studies

2 other studies available for ambroxol and Reperfusion Injury

ArticleYear
Could Ambroxol reduce cytokines in hepatic ischemia-reperfusion injury in rats?
    Bratislavske lekarske listy, 2022, Volume: 123, Issue:5

    Topics: Ambroxol; Animals; Cytokines; Ischemia; Liver; Liver Diseases; Rats; Rats, Wistar; Reperfusion Injur

2022
Donor pretreatment with ambroxol or dexamethasone fails to ameliorate reperfusion injury in experimental lung transplantation.
    Transplant international : official journal of the European Society for Organ Transplantation, 1998, Volume: 11, Issue:3

    Topics: Ambroxol; Animals; Anti-Inflammatory Agents; Bronchoalveolar Lavage Fluid; Dexamethasone; Disease Mo

1998